Beleave Announces Pre-License Inspection Date
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 03/10/17 -- Beleave Inc. ("Beleave" or the "Company") (CSE: BE)(CSE: BE.CN)(CNSX: BE) is pleased to announce that Health Canada has scheduled a pre-license inspection of Beleave''s facility on March 15, 2017.
About Beleave
Beleave Inc. is a biotech company committed to becoming a licensed producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). Beleave''s wholly-owned subsidiary First Access Medical Inc. ("FAM") has applied for a license to cultivate and sell medical cannabis pursuant to the ACMPR. As of the date hereof, FAM has successfully advanced past the review stage, and scheduled its pre-licensing inspection. Beleave''s purpose-built facility is located near Hamilton, Ontario.
Forward-Looking Statements
This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the completion of the ACMPR licensing process, meeting the requirements of the ACMPR, obtaining a license to cultivate pursuant to the ACMPR, and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company''s disclosure documents, which can be found under the Company''s profile on .
Contacts:
Beleave Inc.
Sebastian de Kloet
1 (905) 979 - 5173
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.03.2017 - 09:00 Uhr
Sprache: Deutsch
News-ID 1491923
Anzahl Zeichen: 2374
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Biotech
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 312 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Beleave Announces Pre-License Inspection Date
"
steht unter der journalistisch-redaktionellen Verantwortung von
Beleave Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
